- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Most Popular Stocks
Norwegian Pharmaceuticals & Biotech Most Popular Stocks
Results
16
Most Popular Stocks on the market
16 companies
Photocure
Market Cap: NOK 1.8b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 69.10
7D
-4.6%
1Y
19.8%
Thor Medical
Market Cap: NOK 1.7b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 4.86
7D
-5.4%
1Y
88.5%
ArcticZymes Technologies
Market Cap: NOK 1.1b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 22.20
7D
-1.3%
1Y
52.5%
Nykode Therapeutics
Market Cap: NOK 1.0b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 3.17
7D
15.1%
1Y
18.3%
Vistin Pharma
Market Cap: NOK 935.7m
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 21.10
7D
1.0%
1Y
-11.0%
Lytix Biopharma
Market Cap: NOK 711.8m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 9.48
7D
5.8%
1Y
69.3%
Hofseth BioCare
Market Cap: NOK 705.9m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.42
7D
15.0%
1Y
-54.6%
Navamedic
Market Cap: NOK 546.8m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.80
7D
5.1%
1Y
-6.6%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
-15.6%
Zelluna
Market Cap: NOK 394.0m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 15.00
7D
1.3%
1Y
n/a
Oncoinvent
Market Cap: NOK 194.6m
A clinical stage company, develops radiopharmaceutical therapies against cancer.
ONCIN
NOK 43.45
7D
4.2%
1Y
n/a
Circio Holding
Market Cap: NOK 165.7m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 1.15
7D
4.9%
1Y
75.4%
SoftOx Solutions
Market Cap: NOK 144.4m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.06
7D
-13.0%
1Y
34.8%
EXACT Therapeutics
Market Cap: NOK 117.7m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 1.86
7D
-7.0%
1Y
-45.3%
Arctic Bioscience
Market Cap: NOK 93.0m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.45
7D
1.5%
1Y
9.9%
PCI Biotech Holding
Market Cap: NOK 5.9m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.16
7D
-41.4%
1Y
-87.4%